Does INEBILIZUMAB Cause Off label use? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Off label use have been filed in association with INEBILIZUMAB (UPLIZNA). This represents 30.3% of all adverse event reports for INEBILIZUMAB.
20
Reports of Off label use with INEBILIZUMAB
30.3%
of all INEBILIZUMAB reports
3
Deaths
17
Hospitalizations
How Dangerous Is Off label use From INEBILIZUMAB?
Of the 20 reports, 3 (15.0%) resulted in death, 17 (85.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INEBILIZUMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does INEBILIZUMAB Cause?
Neuromyelitis optica spectrum disorder (17)
Covid-19 (7)
Pneumocystis jirovecii pneumonia (7)
Pneumonia (6)
Pyrexia (6)
Progressive multifocal leukoencephalopathy (5)
Respiratory failure (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)